The 3rd Annual Conference on Regenerative Medicine, hosted by RegMed XB, gathered and attracted nearly 200 attendees. Held on June 18th and 19th in Leuven, Belgium, the event provided a platform for professionals across the entire spectrum of regenerative medicine — from innovative start-ups, researchers, and industry experts to government representatives, health foundations, and visionaries in the field.

What began as an accidental discovery in a chemistry lab has evolved into a deeptech venture with the potential to significantly impact organoid research and regenerative medicine. 

XS Innovations is tackling a major challenge for people with end-stage kidney disease: keeping their blood vessel access open for dialysis. Most patients need a special connection between an artery and a vein in their arm, called an arteriovenous fistula (AVF), to ensure enough blood flows during treatment.